Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Quality and Outcomes
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Quality and Outcomes. 2008;1:92-97
Published online before print November 9, 2008, doi: 10.1161/CIRCOUTCOMES.108.831198
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/2/92    most recent
CIRCOUTCOMES.108.831198v1
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, P. W.F.
Right arrow Articles by O'Donnell, C. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilson, P. W.F.
Right arrow Articles by O'Donnell, C. J.
Related Collections
Right arrow Risk Factors
Right arrow Epidemiology
Right arrowRelated Article

Original Articles

C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study

Peter W.F. Wilson, MD; Michael Pencina, PhD; Paul Jacques, DS; Jacob Selhub, PhD; Ralph D'Agostino, Sr, PhD and Christopher J. O'Donnell, MD, MPH

From EPICORE (P.W.F.W.), Emory University School of Medicine, and the Atlanta VAMC Epidemiology and Genetics Section, Atlanta, Ga; National Heart, Lung, and Blood Institute (C.J.O.D.); National Heart, Lung and Blood Institute’s Framingham Heart Study (M.P., R.D.A., C.J.O.D.), Framingham Mass; Department of Mathematics (M.P., R.D.A.), Boston University, Boston, Mass; Tufts USDA Nutrition Center (P.J., J.S.), Boston, Mass.

Correspondence to Peter W. F. Wilson, MD, Suite 1 North, Emory University School of Medicine, 1256 Briarcliff Rd, and the Atlanta VAMC Epidemiology and Genetics Section, Atlanta, GA 30306. E-mail peter.wf.wilson{at}emory.edu

Received October 23, 2008; accepted October 23, 2008.

Background— The relationship of circulating levels of high-sensitivity C-reactive protein (CRP) with cardiovascular disease (CVD) risk, particularly with consideration of effects at intermediate levels of risk, has not been fully assessed.

Methods and Results— Among 3006 offspring participants in the Framingham Heart Study free of CVD (mean age, 46 years at baseline), there were 129 hard coronary heart disease (CHD) events and 286 total CVD events during 12 years of follow-up. Cox regression, discrimination with area under the receiver operating characteristic curve, and net reclassification improvement were used to assess the role of CRP on vascular risk. In an age-adjusted model that included both sexes, the hazard ratios for new hard CHD and total CVD were significantly associated with higher CRP levels. Similar analyses according to increasing homocysteine level showed significant protective associations for hard CHD but not for total CVD. In multivariable analyses that included age, sex, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, diabetes mellitus, current smoking, hypertension treatment, and homocysteine, the log CRP level remained significantly related to development of hard CHD and total CVD and provided moderate improvement in the discrimination of events. The net reclassification improvement when CRP was added to traditional factors was 5.6% for total CVD (P=0.014) and 11.8% for hard CHD (P=0.009).

Conclusions— Circulating levels of CRP help to estimate risk for initial cardiovascular events and may be used most effectively in persons at intermediate risk for vascular events, offering moderate improvement in reclassification of risk.

Key Words: epidemiology • inflammation • risk factors • statistics


 

CLINICAL PERSPECTIVE

John A. Spertus, MD, handled this manuscript.


Related Article

C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Peter W.F. Wilson, Michael Pencina, Paul Jacques, Jacob Selhub, Ralph D'Agostino, Sr, and Christopher J. O'Donnell
Circ Cardiovasc Qual Outcomes 2008 1: 92-97. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
CirculationHome page
M. J. Pencina, R. B. D'Agostino Sr, M. G. Larson, J. M. Massaro, and R. S. Vasan
Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study
Circulation, June 23, 2009; 119(24): 3078 - 3084.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
N. R. Cook and P. M Ridker
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Ann Intern Med, June 2, 2009; 150(11): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Mora, K. Musunuru, and R. S. Blumenthal
The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines
Clin. Chem., February 1, 2009; 55(2): 219 - 228.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. M Ridker
C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease
Clin. Chem., February 1, 2009; 55(2): 209 - 215.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
R. S Vasan
Commentary: C-reactive protein and risk prediction--moving beyond associations to assessing predictive utility and clinical usefulness
Int. J. Epidemiol., February 1, 2009; 38(1): 231 - 234.
[Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
H. M. Krumholz
Outcomes Research: Myths and Realities
Circ Cardiovasc Qual Outcomes, January 1, 2009; 2(1): 1 - 3.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
C-Reactive Protein and the Framingham Risk Score
Journal Watch Cardiology, November 26, 2008; 2008(1126): 3 - 3.
[Full Text]